Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma
autor
vastutusandmed
Simone Jueliger, John Lyons, Sara Cannito, Illar Pata, Pille Pata, Marianna Shkolnaya, Oriana Lo Re, Marion Peyrou, Francesc Villarroya, Valerio Pazienza, Francesca Rappa, Francesco Cappello, Mohammad Azab, Pietro Taverna, and Manlio Vinciguerra
allikas
Epigenetics
ajakirja aastakäik number kuu
vol. 11, 10
ilmumisaasta
leheküljed
p. 709-720 : ill
märksõna
võtmesõna
decitabine
guadecitabine
hepatocellular carcinoma (HCC)
histone macroH2A1
steatohepatitis
ISSN
1559-2294
märkused
Bibliogr.: 45 ref
TTÜ struktuuriüksus
keel
inglise
Jueliger, S., Lyons, J., Cannito, S., Pata, I., Pata, P., Školnaja, M. et al. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma // Epigenetics (2016) vol. 11, 10, p. 709-720 : ill.